Heparin-induced thrombocytopenia type II in an infant with a congenital heart defect - Anticoagulation during cardiopulmonary bypass with epoprostenol sodium and heparin

Pediatric Critical Care Medicine

Volumn 7, Issue 4, 2006, Pages 383-385

  Von Heymann, Christian ^a   Hagemeyer, Elmar ^a   Kastrup, Marc ^a   Ziemer, Sabine ^a   Proquitté, Hans ^a   Konertz, Wolfgang F ^a   Spies, Claudia ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Epoprostenol sodium; Heparin induced thrombocytopenia type II; Reexposure to heparin

Indexed keywords

HEPARIN; PROSTACYCLIN;

ANTICOAGULATION; ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; CLINICAL FEATURE; CONGENITAL HEART DISEASE; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INFANT; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RISK ASSESSMENT; STERNOTOMY; THROMBOSIS;

ANTICOAGULANTS; CARDIOPULMONARY BYPASS; DRUG THERAPY, COMBINATION; EPOPROSTENOL; FEMALE; HEART DEFECTS, CONGENITAL; HEPARIN; HUMANS; INFANT; PLATELET AGGREGATION INHIBITORS; PREMEDICATION; THROMBOCYTOPENIA;

EID: 33745876559     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000225006.03861.E4     Document Type: Article

References (15)

1. Warkentin TE, Greinacher A: Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003; 76:2121-2131
2. Severin T, Sutor AH: Heparin-induced thrombocytopenia in pediatrics. Semin Thromb Hemost 2001; 27:293-299
3. Butler JT, Sodoma LJ, Doski JJ, et al: Heparin-associated thrombocytopenia and thrombosis as the cause of a fatal thrombus on extracorporeal membrane oxygenation. J Pediatr Surg 1997; 32:768-771
4. Koster A, Crystal GJ, Kuppe H, et al: Acute heparin induced thrombocytopenia type II during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000; 14:300-303
5. Nuttall GA, Oliver WC Jr, Santrach PJ, et al: Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: A prospective observational case series. Anesth Analg 2003; 96:344-350
6. Aouifi A, Blanc P, Piriou V, et al: Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia. Ann Thorac Surg 2001; 71:678-683
7. Eichler P, Raschke R, Lubenow N, et al: The new ID-heparin/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays. Br J Haematol 2002; 116:887-991
8. Fischer KG: Hirudin in renal insufficiency. Semin Thromb Hemost 2002; 28:467-482
9. Scott LK, Grier LR, Conrad SA: Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban. Pediatr Crit Care Med 2006 Feb 7; Publish Ahead of Print
10. Gorman RR, Bunting S, Miller OV: Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 1977; 13:377-388
11. Aszodi A, Pfeifer A, Ahmad M, et al: The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP-and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. Embo J 1999; 18:37-48
12. Horstrup K, Jablonka B, Honig-Liedl P, et al: Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser 157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur J Biochem 1994; 225:21-27
13. Antoniou T, Kapetanakis EI, Theodoraki K, et al: Cardiac surgery in patients with heparin-induced thrombocytopenia using preoperatively determined dosages of iloprost. Heart Surg Forum 2002; 5:354-357
14. Lucas FV, Skrinska VA, Chisolm GM, et al: Stability of prostacyclin in human and rabbit whole blood and plasma. Thromb Res 1986; 43:379-387
15. Wilhelm MJ, Schmid C, Kececioglu D, et al: Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172. Ann Thorac Surg 1996; 61:920-924